Switching opioids to transdermal fentanyl in a clinical setting;Opioidwechsel auf transdermales fentanyl im klinischen alltag

Schmerz

Volumn 13, Issue 4, 1999, Pages 273-278

  Elsner, F ^a   Radbruch, L ^a   Sabatowski, R ^a   Brunsch Radbruch, A ^a   Loick, G ^a   Grond, S ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Cancer pain management; Conversion ratio; Opioid rotation; Transdermal fentanyl

Indexed keywords

BUPRENORPHINE; FENTANYL; LEVOMETHADONE; MORPHINE SULFATE; NALOXONE; OPIATE AGONIST; PIRITRAMIDE; TILIDINE; TRAMADOL;

CANCER PAIN; CONSTIPATION; DRUG EFFICACY; DRUG UTILIZATION; DYSPHAGIA; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; PAIN ASSESSMENT; PATIENT SATISFACTION; REVIEW; TRANSDERMAL DRUG ADMINISTRATION; VOMITING;

EID: 0032848557     PISSN: 0932433X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004820050210     Document Type: Review

References (13)

1. Ahmedzai S, Brooks D (1997) Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life.The TTS-Fentanyl Comparative Trial Group. J Pain Symptom Manage 13:254
2. Brunsch-Radbruch A, Radbruch L, Steden E, Kulbe C, Sabatowski R, Grond S (1997) Transdermales Fentanyl in der klinischen Praxis - eine Anwendungsbeobachtung. Schmerz [Suppl 1] 11:53
3. De Stoutz ND, Bruera E, Suarez-Almazor M (1995) Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage 10:378
4. Donner B, Zenz M, Tryba M, Strumpf M (1996) Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain. Pain 64:527
5. Donner B, Strumpf M, Dertwinkel R,Zenz M (1997) Richtige Anwendung von Fentanyl TTS entscheidend. Dtsch Arztebl 94:A598
6. Grond S, Zech D, Diefenbach C, Radbruch L, Lehmann KA (1996) Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain 64:107
7. Grond S,Zech D, Lehmann KA, Radbruch L, Breitenbach H, Hertel D (1997) Transdermal fentanyl in the long-term treatment of cancer pain: a prospective study of 50 patients with advanced cancer of the gastrointestinal tract or the head and neck region. Pain 69:1
8. Hammack JE, Mailliard JA, Loprinzi CL, Rospond RM, O'Fallon JR,Wilwerding MB, Reuter NF, Michalak JC, Fidler P, Miser AW (1996) Transdermal fentanyl in the management of cancer pain in ambulatory patients: an open-label pilot study. J Pain Symptom Manage 12:234
9. Hildebrandt J,Pfingsten M (1995) Organisation und Leistungsvermögen von Schmerzambulanzen. Onkologie 1:343
10. Korte W, De Stoutz N, Morant R (1996) Day-to-day titration to initiate transdermal fentanyl in patients with cancer pain: short- and long-term experiences in a prospective study of 39 patients. J Pain Symptom Manage 11:139
11. Radbruch L, Kolibay F, Brunsch-Radbruch A, Grond S (1998) Transdermale Applikation von Fentanyl - Klinische Anwendung. Spektr Onkol 2:17
12. World Health Organisation (1986) Cancer pain relief. World Health Organisation, Genf
13. Zenz M, Donner B, Strumpf M (1994) Withdrawal symptoms during therapy with transdermal fentanyl (fentanyl TTS)? [see comments]. J Pain Symptom Manage 9:54